The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review.

Journal of Diabetes and Metabolic Disorders
Justine SciberrasSarah Cuschieri


Diabetes Mellitus is a chronic disease and a global epidemic. It is a known fact that co-morbidities, including Diabetes Mellitus, pose a higher risk of infection by COVID-19. Additionally, the outcomes following infection are far worse than in people without such co-morbities.Factors contributing to the development of type 2 diabetes mellitus (T2DM) have long been established, yet this disease still bestows a substantial global burden. The aim was to provide a comprehensive review of the burden of diabetes pre-COVID-19 and the additional impact sustained by the diabetes population and healthcare systems during the COVID-19 pandemic, while providing recommendations of how this burden can be subsided. Literature searches were carried out on 'Google Scholar' and 'PubMed' to identify relevant articles for the scope of this review. Information was also collected from reliable sources such as the World Health Organisation and the International Diabetes Federation. T2DM presented with economic, social and health burdens prior to COVID-19 with an significant 'Disability Adjusted Life Years' impact. Whilst people with diabetes are more susceptible to COVID-19, enforcing lockdown regulations set by the Public Health department to reduce...Continue Reading


Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Nov 1, 2003·Sleep Medicine·R P SkomroM H Kryger
Jun 9, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·J K YangJ C N Chan
May 15, 2007·Diabetes Research and Clinical Practice·Yuzo SatoNaoya Nakai
Jan 19, 2008·European Journal of Clinical Nutrition·R M van Dam, J C Seidell
Apr 30, 2013·Seminars in Thrombosis and Hemostasis·Sigrid K BraekkanFrits R Rosendaal
Sep 18, 2016·Lancet·Slim SlamaMarcello Tonelli
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association
Jan 17, 2017·Obesity Science & Practice·S CuschieriJ Mamo
Apr 14, 2017·Lancet·Samuel L DickmanSteffie Woolhandler
Jun 12, 2017·The Lancet. Diabetes & Endocrinology·Ranjit Mohan AnjanaUNKNOWN ICMR–INDIAB Collaborative Study Group
Dec 9, 2017·Nature Reviews. Endocrinology·Yan ZhengFrank B Hu
Nov 23, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·J Fagg, J Valabhji
Mar 1, 2020·BMJ : British Medical Journal·John Watkins
Mar 15, 2020·The Lancet. Respiratory Medicine·Lei FangMichael Roth
Apr 1, 2020·The New England Journal of Medicine·Muthiah VaduganathanScott D Solomon
Apr 4, 2020·Nature Reviews. Endocrinology·Stefan R BornsteinBernhard O Boehm
Apr 15, 2020·Journal of Diabetes·Weiqing WangGuang Ning
Apr 16, 2020·Current Cardiology Reports·Juan Simon Rico-MesaAllen S Anderson
Apr 21, 2020·Diabetes & Metabolic Syndrome·Mainak BanerjeeRimesh Pal
Apr 23, 2020·Circulation·Naveed SattarJohn J V McMurray
Apr 28, 2020·Obesity·Ilja L Kruglikov, Philipp E Scherer
May 10, 2020·Diabetes Technology & Therapeutics·Anne L Peters, Satish Garg
May 11, 2020·Diabetes & Metabolic Syndrome·Rimesh Pal, Sanjay K Bhadada
May 13, 2020·Diabetes Technology & Therapeutics·Morgan S JonesJohn B Buse
May 15, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·T Skinner, J Speight
May 28, 2020·Journal of Diabetes and Its Complications·Sarah Cuschieri, Stephan Grech
Jun 9, 2020·European Journal of Endocrinology·Deborah J WakeRobert K Semple
Jun 11, 2020·Journal of Diabetes Investigation·Keiko Naruse

❮ Previous
Next ❯


May 18, 2021·Therapeutic Advances in Infectious Disease·Andrew Peter KyazzeIrene Andia-Biraro

❮ Previous
Next ❯

Software Mentioned

Google Scholar

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.